Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States

Abstract

Our results indicate that gold-standard monitoring for patients with cirrhosis is cost-effective, attributed to a higher probability of benefiting from a curative treatment and so a higher survival probability. (Hepatology 2017;65:1237-1248).